Calcium Crystal Deposition Diseases: Update on Pathogenesis and Manifestations

Rheumatic Disease Clinics of North America

Volumn 32, Issue 2, 2006, Pages 383-400

  Molloy, E S ^a   McCarthy, G M ^b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM PYROPHOSPHATE; CYTOKINE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PROSTAGLANDIN; TOLL LIKE RECEPTOR;

APOPTOSIS; ARTHRITIS; CARTILAGE CELL; CELL INTERACTION; CLINICAL FEATURE; ENZYME INDUCTION; GOUT; HUMAN; JOINT DEGENERATION; LEUKOCYTE ACTIVATION; MITOGENESIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RECEPTOR BINDING; REVIEW; UPREGULATION; CHONDROCALCINOSIS; CRYSTALLIZATION; METABOLISM;

CALCIUM PHOSPHATES; CALCIUM PYROPHOSPHATE; CHONDROCALCINOSIS; CRYSTALLIZATION; HUMANS;

EID: 33746233540     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2006.02.001     Document Type: Review

References (98)

1. McCarthy G.M., Westfall P.R., Masuda I., et al. Basic calcium phosphate crystals activate human osteoarthritic synovial fibroblasts and induce matrix metalloproteinase-13 (collagenase-3) in adult porcine articular chondrocytes. Ann Rheum Dis 60 (2001) 399-406
2. Ea H.-K., Uzan B., Rey C., et al. Octacalcium phosphate crystals directly stimulate expression of inducible nitric oxide synthase through p38 and JNK mitogen-activated protein kinases in articular chondrocytes. Arthritis Res Ther 7 (2005) R915-R926
3. Halverson P.B., Greene A., and Cheung H.S. Intracellular calcium responses to basic calcium phosphate crystals in fibroblasts. Osteoarthritis Cartilage 6 (1998) 324-329
4. Sun Y., Zeng X.R., Wenger L., et al. Basic calcium phosphate crystals stimulate the endocytotic activity of cells-inhibition by anti-calcification agents. Biochem Biophys Res Commun 312 (2003) 1053-1059
5. Cheung H.S., Story M.T., and McCarty D.J. Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum 27 (1984) 668-674
6. Hamilton J.A., McCarthy G., and Whitty G. Inflammatory microcrystals induce murine macrophage survival and DNA synthesis. Arthritis Res 3 (2001) 242-246
7. Cheung H.S., and McCarty D.J. Mitogenesis induced by calcium-containing crystals. Role of intracellular dissolution. Exp Cell Res 157 (1985) 63-70
8. Rothenberg R.J., and Cheung H. Rabbit synoviocyte inositol phospholipid metabolism is stimulated by hydroxyapatite crystals. Am J Physiol 254 (1988) C554-C559
9. Mitchell P.G., Pledger W.J., and Cheung H.S. Molecular mechanism of basic calcium phosphate crystal-induced mitogenesis. Role of protein kinase C. J Biol Chem 264 (1989) 14071-14077
10. McCarthy G.M., Augustine J.A., Baldwin A.S., et al. Molecular mechanism of basic calcium phosphate crystal-induced activation of human fibroblasts. Role of nuclear factor kappab, activator protein 1, and protein kinase c. J Biol Chem 273 (1998) 35161-35169
11. Nair D., Misra R.P., Sallis J.D., et al. Phosphocitrate inhibits a basic calcium phosphate and calcium pyrophosphate dihydrate crystal-induced mitogen-activated protein kinase cascade signal transduction pathway. J Biol Chem 272 (1997) 18920-18925
12. Zeng X.R., Sun Y., Wenger L., et al. Induction of early growth response gene Egr2 by basic calcium phosphate crystals through a calcium-dependent protein kinase C-independent p44/42 mitogen-activated protein kinase pathway. Cells Tissues Organs 174 (2003) 63-72
13. Zeng X.R., Sun Y., Wenger L., et al. Basic calcium phosphate crystal-induced Egr-1 expression stimulates mitogenesis in human fibroblasts. Biochem Biophys Res Commun 330 (2005) 658-664
14. Cheung H.S., Halverson P.B., and McCarty D.J. Release of collagenase, neutral protease, and prostaglandins from cultured mammalian synovial cells by hydroxyapatite and calcium pyrophosphate dihydrate crystals. Arthritis Rheum 24 (1981) 1338-1344
15. McCarthy G.M., Mitchell P.G., and Cheung H.S. The mitogenic response to stimulation with basic calcium phosphate crystals is accompanied by induction and secretion of collagenase in human fibroblasts. Arthritis Rheum 34 (1991) 1021-1030
16. McCarthy G.M., Mitchell P.G., Struve J.A., et al. Basic calcium phosphate crystals cause coordinate induction and secretion of collagenase and stromelysin. J Cell Physiol 153 (1992) 140-146
17. Reuben P.M., Wenger L., Cruz M., et al. Induction of matrix metalloproteinase-8 in human fibroblasts by basic calcium phosphate and calcium pyrophosphate dihydrate crystals: effect of phosphocitrate. Connect Tissue Res 42 (2001) 1-12
18. Halverson P.B., Cheung H.S., McCarty D.J., et al. "Milwaukee shoulder"-association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. II. Synovial fluid studies. Arthritis Rheum 24 (1981) 474-483
19. Bai G., Howell D.S., Howard G.A., et al. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts. Osteoarthritis Cartilage 9 (2001) 416-422
20. Martel-Pelletier J., McCollum R., Fujimoto N., et al. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70 (1994) 807-815
21. Dean D.D., Martel-Pelletier J., Pelletier J.P., et al. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84 (1989) 678-685
22. McCarthy G.M., Cheung H.S., Abel S.M., et al. Basic calcium phosphate crystal-induced collagenase production: role of intracellular crystal dissolution. Osteoarthritis Cartilage 6 (1998) 205-213
23. Brogley M.A., Cruz M., and Cheung H.S. Basic calcium phosphate crystal induction of collagenase 1 and stromelysin expression is dependent on a p42/44 mitogen-activated protein kinase signal transduction pathway. J Cell Physiol 180 (1999) 215-224
24. Sun Y., Wenger L., Brinckerhoff C.E., et al. Basic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-Fos/AP-1/metalloproteinase 1 pathway. Involvement of transcription factor binding sites AP-1 and PEA-3. J Biol Chem 277 (2002) 1544-1552
25. Reuben P.M., Brogley M.A., Sun Y., et al. Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J Biol Chem 277 (2002) 15190-15198
26. Reuben P.M., Sun Y., and Cheung H.S. Basic calcium phosphate crystals activate p44/42 MAPK signal transduction pathway via protein kinase Cmicro in human fibroblasts. J Biol Chem 279 (2004) 35719-35725
27. Goldring S.R., Goldring M.B., and Buckwalter J. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 427 (2004) S27-S36
28. Picher M., Graff R.D., and Lee G.M. Extracellular nucleotide metabolism and signaling in the pathophysiology of articular cartilage. Arthritis Rheum 48 (2003) 2722-2736
29. Morgan M.P., Whelan L.C., Sallis J.D., et al. Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta. Arthritis Rheum 50 (2004) 1642-1649
30. Meng Z.H., Hudson A.P., Schumacher Jr. H.R., et al. Monosodium urate, hydroxyapatite, and calcium pyrophosphate crystals induce tumor necrosis factor-alpha expression in a mononuclear cell line. J Rheumatol 24 (1997) 2385-2388
31. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res 96 (2005) 1248-1256
32. Hardy M.M., Seibert K., Manning P.T., et al. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 46 (2002) 1789-1803
33. Siegle I., Klein T., Backman J.T., et al. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 41 (1998) 122-129
34. Pelletier J.P., Mineau F., Fernandes J.C., et al. Diacerhein and rhein reduce the interleukin 1beta stimulated inducible nitric oxide synthesis level and activity while stimulating cyclooxygenase-2 synthesis in human osteoarthritic chondrocytes. J Rheumatol 25 (1998) 2417-2424
35. Amin A.R., Attur M., Patel R.N., et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 99 (1997) 1231-1237
36. Knorth H., Dorfmuller P., Lebert R., et al. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro. Osteoarthritis Cartilage 12 (2004) 658-666
37. Cheung H.S., Halverson P.B., and McCarty D.J. Phagocytosis of hydroxyapatite or calcium pyrophosphate dihydrate crystals by rabbit articular chondrocytes stimulates release of collagenase, neutral protease, and prostaglandins E2 and F2 alpha. Proc Soc Exp Biol Med 173 (1983) 181-189
38. Rothenberg R.J. Modulation of prostaglandin E2 synthesis in rabbit synoviocytes. Arthritis Rheum 30 (1987) 266-274
39. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25 (1999) 269-282
40. Amin A.R., Di Cesare P.E., Vyas P., et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 182 (1995) 2097-2102
41. Pelletier J.P., Jovanovic D., Fernandes J.C., et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 41 (1998) 1275-1286
42. Pelletier J., Jovanovic D., Fernandes J.C., et al. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor. Osteoarthritis Cartilage 7 (1999) 416-418
43. Pelletier J.P., Lascau-Coman V., Jovanovic D., et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. J Rheumatol 26 (1999) 2002-2014
44. Pelletier J.P., Jovanovic D.V., Lascau-Coman V., et al. Selective inhibition of inducible nitric oxide synthase reduces progression of experimental osteoarthritis in vivo: possible link with the reduction in chondrocyte apoptosis and caspase 3 level. Arthritis Rheum 43 (2000) 1290-1299
45. Hashimoto S., Ochs R.L., Rosen F., et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 95 (1998) 3094-3099
46. Whelan L., O'Byrne J.M., Sallis J.D., et al. Basic calcium phosphate crystals stimulate nitric oxide synthase and modulate bcl-2/bax expression in human synovial fibroblasts. Arthritis Rheum 46 (2002) S140
47. Dieppe P.A., Crocker P.R., Corke C.F., et al. Synovial fluid crystals. Q J Med 48 (1979) 533-553
48. Gibilisco P.A., Schumacher Jr. H.R., Hollander J.L., et al. Synovial fluid crystals in osteoarthritis. Arthritis Rheum 28 (1985) 511-515
49. Nalbant S., Martinez J.A., Kitumnuaypong T., et al. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 11 (2003) 50-54
50. Swan A., Chapman B., Heap P., et al. Submicroscopic crystals in osteoarthritic synovial fluids. Ann Rheum Dis 53 (1994) 467-470
51. Buckwalter J.A., Saltzman C., Brown T., et al. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 427 (2004) S6-S15
52. Halverson P.B., and McCarty D.J. Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis 45 (1986) 603-605
53. Carroll G.J., Stuart R.A., Armstrong J.A., et al. Hydroxyapatite crystals are a frequent finding in osteoarthritic synovial fluid, but are not related to increased concentrations of keratan sulfate or interleukin 1 beta. J Rheumatol 18 (1991) 861-866
54. Dieppe P.A., Doherty M., Macfarlane D.G., et al. Apatite associated destructive arthritis. Br J Rheumatol 23 (1984) 84-91
55. McCarty D.J., Halverson P.B., Carrera G.F., et al. "Milwaukee shoulder"-association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects. Arthritis Rheum 24 (1981) 464-473
56. Neer II C.S., Craig E.V., and Fukuda H. Cuff-tear arthropathy. J Bone Joint Surg [Am] 65-A (1983) 1232-1244
57. McCarty D.J., Swanson A.B., and Ehrhart R.H. Hemorrhagic rupture of the shoulder. J Rheumatol 21 (1994) 1134-1137
58. Pons-Estel B.A., Gimenez C., Sacnun M., et al. Familial osteoarthritis and Milwaukee shoulder associated with calcium pyrophosphate and apatite crystal deposition. J Rheumatol 27 (2000) 471-480
59. Bosworth B.M. Calcium deposits in the shoulder and subacromial bursitis. A survey of 12,222 shoulders. JAMA 116 (1941) 2477-2482
60. Sarkar K., and Uhthoff H.K. Ultrastructural localization of calcium in calcifying tendinitis. Arch Pathol Lab Med 102 (1978) 266-269
61. Fam A.G., and Rubenstein J. Hydroxyapatite pseudopodagra. A syndrome of young women. Arthritis Rheum 32 (1989) 741-747
62. McCarthy G.M., Carrera G.F., and Ryan L.M. Acute calcific periarthritis of the finger joints: a syndrome of women. J Rheumatol 20 (1993) 1077-1080
63. Dayer J.M., Evequoz V., Zavadil-Grob C., et al. Effect of synthetic calcium pyrophosphate and hydroxyapatite crystals on the interaction of human blood mononuclear cells with chondrocytes, synovial cells, and fibroblasts. Arthritis Rheum 30 (1987) 1372-1381
64. Dieppe P.A., Doherty M., and Papadimitriou G.M. Inflammatory responses to intradermal crystals in healthy volunteers and patients with rheumatic diseases. Rheumatol Int 2 (1982) 55-58
65. Stary H.C. Natural history of calcium deposits in atherosclerosis progression and regression. Z Kardiol 89 Suppl 2 (2000) 28-35
66. Arad Y., Spadaro L.A., Goodman K., et al. Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol 36 (2000) 1253-1260
67. Fitzgerald P.J., Ports T.A., and Yock P.G. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 86 (1992) 64-70
68. Bostrom K., Watson K.E., Horn S., et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91 (1993) 1800-1809
69. Doherty T.M., Asotra K., Fitzpatrick L.A., et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 100 (2003) 11201-11206
70. Uzui H., Harpf A., Liu M., et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: role of activated macrophages and inflammatory cytokines. Circulation 106 (2002) 3024-3030
71. Frappart L., Boudeulle M., Boumendil J., et al. Structure and composition of microcalcifications in benign and malignant lesions of the breast: study by light microscopy, transmission and scanning electron microscopy, microprobe analysis, and X-ray diffraction. Hum Pathol 15 (1984) 880-889
72. Holme T.C., Reis M.M., Thompson A., et al. Is mammographic microcalcification of biological significance?. Eur J Surg Oncol 19 (1993) 250-253
73. Tabar L., Chen H.H., Duffy S.W., et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet 355 (2000) 429-433
74. Morgan M.P., Cooke M.M., Christopherson P.A., et al. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol Carcinog 32 (2001) 111-117
75. Cooke M.M., McCarthy G.M., Sallis J.D., et al. Phosphocitrate inhibits calcium hydroxyapatite induced mitogenesis and upregulation of matrix metalloproteinase-1, interleukin-1beta and cyclooxygenase-2 mRNA in human breast cancer cell lines. Breast Cancer Res Treat 79 (2003) 253-263
76. Rolland P.H., Martin P.M., Jacquemier J., et al. Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64 (1980) 1061-1070
77. Dunne A., and O'Neill L.A. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett 579 (2005) 3330-3335
78. Rhee S.H., and Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 275 (2000) 34035-34040
79. Lee J.Y., Zhao L., Youn H.S., et al. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J Biol Chem 279 (2004) 16971-16979
80. Lee J.Y., Sohn K.H., Rhee S.H., et al. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276 (2001) 16683-16689
81. Seibl R., Birchler T., Loeliger S., et al. Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162 (2003) 1221-1227
82. Seibl R., Kyburz D., Lauener R.P., et al. Pattern recognition receptors and their involvement in the pathogenesis of arthritis. Curr Opin Rheumatol 16 (2004) 411-418
83. Pierer M., Rethage J., Seibl R., et al. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172 (2004) 1256-1265
84. Liu-Bryan R., Pritzker K., Firestein G.S., et al. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol 174 (2005) 5016-5023
85. Hoch R.C., Schraufstatter I.U., and Cochrane C.G. In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors. J Lab Clin Med 128 (1996) 134-145
86. Detmers P.A., Lo S.K., Olsen-Egbert E., et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 171 (1990) 1155-1162
87. Liu R., O'Connell M., Johnson K., Pritzker K., et al. Extracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum 43 (2000) 1145-1155
88. Tudan C., Jackson J.K., Charlton L., et al. Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and phosphatidylinositol-3-kinase-independent pathways. Biochem J 331 Pt 2 (1998) 531-537
89. Tudan C., Jackson J.K., Pelech S.L., et al. Selective inhibition of protein kinase C, mitogen-activated protein kinase, and neutrophil activation in response to calcium pyrophosphate dihydrate crystals, formyl-methionyl-leucyl-phenylalanine, and phorbol ester by O-(chloroacetyl-carbamoyl) fumagillol (AGM-1470; TNP-470). Biochem Pharmacol 58 (1999) 1869-1880
90. Jackon J.K., Tudan C., and Burt H.M. The involvement of phospholipase C in crystal induced human neutrophil activation. J Rheumatol 27 (2000) 2877-2885
91. Tudan C., Jackson J.K., Higo T.T., et al. Calcium pyrophosphate dihydrate crystal associated induction of neutrophil activation and repression of TNF-alpha-induced apoptosis is mediated by the p38 MAP kinase. Cell Signal 16 (2004) 211-221
92. Tudan C., Jackson J.K., Blanis L., et al. Inhibition of TNF-alpha-induced neutrophil apoptosis by crystals of calcium pyrophosphate dihydrate is mediated by the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways up-stream of caspase 3. J Immunol 165 (2000) 5798-5806
93. Bouchard L., de Medicis R., Lussier A., et al. Inflammatory microcrystals alter the functional phenotype of human osteoblast-like cells in vitro: synergism with IL-1 to overexpress cyclooxygenase-2. J Immunol 168 (2002) 5310-5317
94. Waguri-Nagaya Y., Kubota Y., Sekiya I., et al. Extensor tendon rupture related to calcium pyrophosphate crystal deposition disease. Rheumatol Int 21 (2002) 243-246
95. Sato Y., Yasuda T., Konno S., et al. Pseudogout showing meningoencephalitic symptoms: crowned dens syndrome. Intern Med 43 (2004) 865-868
96. Muthukumar N., Karuppaswamy U., and Sankarasubbu B. Calcium pyrophosphate dihydrate deposition disease causing thoracic cord compression: case report. Neurosurgery 46 (2000) 222-225
97. Muthukumar N., and Karuppaswamy U. Tumoral calcium pyrophosphate dihydrate deposition disease of the ligamentum flavum. Neurosurgery 53 (2003) 103-108 [discussion: 108-9]
98. Yamakawa K., Iwasaki H., Ohjimi Y., et al. Tumoral calcium pyrophosphate dihydrate crystal deposition disease. A clinicopathologic analysis of five cases. Pathol Res Pract 197 (2001) 499-506